BG62133B1 - Метод за получаване на производни на4а,5,9,10,11,12-хексахидро-6н-бензофуро (3а,3,2-еf)(2)бензазепин - Google Patents

Метод за получаване на производни на4а,5,9,10,11,12-хексахидро-6н-бензофуро (3а,3,2-еf)(2)бензазепин Download PDF

Info

Publication number
BG62133B1
BG62133B1 BG101417A BG10141797A BG62133B1 BG 62133 B1 BG62133 B1 BG 62133B1 BG 101417 A BG101417 A BG 101417A BG 10141797 A BG10141797 A BG 10141797A BG 62133 B1 BG62133 B1 BG 62133B1
Authority
BG
Bulgaria
Prior art keywords
group
compound
general formula
aralkyl
hydrogen
Prior art date
Application number
BG101417A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG101417A (en
Inventor
Laszlo Czollner
Johannes Froehlich
Ulrich Jordis
Bernhard Kueenburg
Original Assignee
Sanochemia Pharmazeutika Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AT198094A external-priority patent/AT401058B/de
Application filed by Sanochemia Pharmazeutika Ag filed Critical Sanochemia Pharmazeutika Ag
Publication of BG101417A publication Critical patent/BG101417A/xx
Publication of BG62133B1 publication Critical patent/BG62133B1/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
BG101417A 1994-10-21 1997-04-16 Метод за получаване на производни на4а,5,9,10,11,12-хексахидро-6н-бензофуро (3а,3,2-еf)(2)бензазепин BG62133B1 (bg)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AT198094A AT401058B (de) 1994-10-21 1994-10-21 Verfahren zum herstellen von derivaten des 4a,5, 9,10,11,12,-hexahydro-6h-benzofuro(3a,-3,2-ef) (2)benzazepins
US48710295A 1995-06-07 1995-06-07
PCT/AT1995/000208 WO1996012692A1 (de) 1994-10-21 1995-10-23 VERFAHREN ZUM HERSTELLEN VON DERIVATEN DES 4a,5,9,10,11,12,-HEXAHYDRO-6H-BENZOFURO[3a,3,2-ef][2]BENZAZEPINS

Publications (2)

Publication Number Publication Date
BG101417A BG101417A (en) 1997-12-30
BG62133B1 true BG62133B1 (bg) 1999-03-31

Family

ID=25597335

Family Applications (1)

Application Number Title Priority Date Filing Date
BG101417A BG62133B1 (bg) 1994-10-21 1997-04-16 Метод за получаване на производни на4а,5,9,10,11,12-хексахидро-6н-бензофуро (3а,3,2-еf)(2)бензазепин

Country Status (27)

Country Link
US (1) US6043359A (cs)
EP (1) EP0787115B1 (cs)
JP (1) JP4187786B2 (cs)
KR (1) KR100352212B1 (cs)
CN (1) CN1069624C (cs)
AT (1) ATE188460T1 (cs)
AU (1) AU695352B2 (cs)
BG (1) BG62133B1 (cs)
BR (1) BR9509406A (cs)
CA (1) CA2203183C (cs)
CZ (1) CZ295528B6 (cs)
DE (1) DE59507585D1 (cs)
DK (1) DK0787115T3 (cs)
ES (1) ES2106700T3 (cs)
FI (1) FI114477B (cs)
GR (2) GR980300015T1 (cs)
HU (1) HU217207B (cs)
MX (1) MX9702892A (cs)
NO (2) NO313234B1 (cs)
NZ (1) NZ294191A (cs)
PL (1) PL184590B1 (cs)
PT (1) PT787115E (cs)
RO (1) RO118419B1 (cs)
RU (1) RU2146258C1 (cs)
SI (1) SI0787115T1 (cs)
SK (1) SK283877B6 (cs)
WO (1) WO1996012692A1 (cs)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9519267D0 (en) * 1995-09-21 1995-11-22 Chiroscience Ltd Preparation of alkaloids
AT403803B (de) 1996-04-19 1998-05-25 Sanochemia Ltd Neue benzazepinderivate, diese enthaltende arzneimittel und verwendung derselben zum herstellen von arzneimitteln
GB9610887D0 (en) * 1996-05-24 1996-07-31 N H S Trust Process
GB9707413D0 (en) * 1997-04-11 1997-05-28 Chiroscience Ltd Process
ES2215885T3 (es) * 2000-03-31 2004-10-16 Sanochemia Pharmazeutika Aktiengesellschaft Nuevos derivados y analogos de la galantamina.
US6897228B2 (en) * 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
US6996261B2 (en) * 2001-01-30 2006-02-07 Decharms R Christopher Methods for physiological monitoring, training, exercise and regulation
DE10129265A1 (de) * 2001-06-18 2003-01-02 Hf Arzneimittelforsch Gmbh Wirkstoff-Kombination zur medikamentösen Sucht- oder Rauschmitteltherapie
DE10134038A1 (de) * 2001-07-12 2003-02-06 Hf Arzneimittelforsch Gmbh Wirkstoff-Kombination zur medikamentösen Therapie der Nikotinabhängigkeit
US20060111341A1 (en) * 2003-09-29 2006-05-25 Angelika Bodenteich Use of galanthamine and the derivatives thereof in the production of medicaments
AT414125B (de) * 2003-09-29 2006-09-15 Sanochemia Pharmazeutika Ag Neue derivate des 4a,5,9,10,11,12-hexahydro- benzofuro(3a,3,2)(2) benzazepin, verfahren zu deren herstellung sowie deren verwendung zur herstellung von arzneimitteln
CA2552114A1 (en) * 2003-12-31 2005-07-21 Actavis Group Hf Solid dosage formulations of galantamine
EP1763337A2 (en) * 2003-12-31 2007-03-21 Actavis Group HF Immediate, controlled and sustained release formulations of galanthamine
WO2006013546A2 (en) * 2004-07-28 2006-02-09 Ranbaxy Laboratories Limited Process for the preparation of pure galantamine
WO2006018703A2 (en) * 2004-08-16 2006-02-23 Ranbaxy Laboratories Limited Processes for preparation of narwedine and its use in the synthesis of galantamine
ATE459627T1 (de) * 2005-05-03 2010-03-15 Medichem Sa Synthesen und herstellungen von narwedin und verwandten neuen verbindungen
AT504663B1 (de) 2007-02-22 2008-07-15 Sanochemia Pharmazeutika Ag Verfahren zum herstellen von hochreinen 4a,5,9,10,11,12,-hexahydro-6h-benzofuro(3a,3,2- f)(2) benzazepinen sowie dessen derivaten
SI2146719T1 (sl) * 2007-04-12 2013-10-30 Scinopharm Taiwan Ltd. Postopek za pripravo galantamina
EP2009015B1 (en) 2007-06-18 2012-01-11 Aurobindo Pharma Limited Process for the preparation of galantamine hydrobromide
AT507039A1 (de) 2008-06-26 2010-01-15 Sanochemia Pharmazeutika Ag Verfahren zum herstellen von hochreinen benzazepinderivaten
DE102008056086A1 (de) * 2008-11-06 2010-05-12 Gp Solar Gmbh Additiv für alkalische Ätzlösungen, insbesondere für Texturätzlösungen sowie Verfahren zu dessen Herstellung
WO2013160728A1 (en) 2012-04-26 2013-10-31 Alma Mater Studiorum - Universita' Di Bologna Dual targeting compounds for the treatment of alzheimer's disease
CN102924462B (zh) * 2012-10-24 2015-01-14 华东师范大学 1,2,3,4,5,9-取代苯并吖庚因类化合物的合成方法
CN103345954B (zh) * 2013-06-20 2016-06-08 哈尔滨工业大学 一种高锰酸盐与活性炭联用去除放射性碘污染的水处理方法
CN109336897A (zh) * 2018-12-06 2019-02-15 河南中帅医药科技股份有限公司 一种氢溴酸加兰他敏工业化制备方法
CN112521364B (zh) * 2019-09-17 2023-09-05 鲁南制药集团股份有限公司 一种加兰他敏中间体化合物v
CN112521395B (zh) * 2019-09-17 2023-09-05 鲁南制药集团股份有限公司 一种加兰他敏的制备方法
CN110714208B (zh) * 2019-10-30 2020-12-29 常州工学院 一种电催化制备6-(磺酰甲基)菲啶类化合物的方法
CN118908968B (zh) * 2024-10-09 2025-03-04 威胜生物医药(苏州)股份有限公司 一种加兰他敏中间体衍生物及其催化氧化制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BG28325A1 (en) * 1978-11-21 1980-04-15 Vlakhov Method of obtaining of enons navedine type and their derivatives
US4290862A (en) * 1979-11-14 1981-09-22 Edinen Centar P Chimia Method for the preparation of narwedine-type enones
US4663318A (en) * 1986-01-15 1987-05-05 Bonnie Davis Method of treating Alzheimer's disease
ATE411026T1 (de) * 1987-05-04 2008-10-15 Bonnie Davis Mittel zur behandlung der alzheimer-krankheit
US5428159A (en) * 1994-04-08 1995-06-27 Ciba-Geigy Corporation Method of manufacture of (-)-galanthamine in high yield and purity substantially free of epigalanthamine

Also Published As

Publication number Publication date
NO313234B1 (no) 2002-09-02
RO118419B1 (ro) 2003-05-30
EP0787115A1 (de) 1997-08-06
JP4187786B2 (ja) 2008-11-26
ES2106700T1 (es) 1997-11-16
ES2106700T3 (es) 2000-05-16
NZ294191A (en) 1998-10-28
GR980300015T1 (en) 1998-03-31
SK48397A3 (en) 1997-11-05
JPH10507457A (ja) 1998-07-21
AU3693895A (en) 1996-05-15
US6043359A (en) 2000-03-28
AU695352B2 (en) 1998-08-13
HUT77716A (hu) 1998-07-28
DE59507585D1 (de) 2000-02-10
NO971645L (no) 1997-05-07
FI114477B (fi) 2004-10-29
ATE188460T1 (de) 2000-01-15
MX9702892A (es) 1998-07-31
GR3032965T3 (en) 2000-07-31
HU217207B (hu) 1999-12-28
NO971645D0 (no) 1997-04-10
DK0787115T3 (da) 2000-05-08
BR9509406A (pt) 1998-11-03
CN1170395A (zh) 1998-01-14
PL184590B1 (pl) 2002-11-29
CZ119597A3 (en) 1997-08-13
NO971796L (no) 1997-05-28
CN1069624C (zh) 2001-08-15
KR100352212B1 (ko) 2003-04-18
FI971609A0 (fi) 1997-04-16
FI971609L (fi) 1997-06-02
BG101417A (en) 1997-12-30
SI0787115T1 (en) 2000-04-30
SK283877B6 (sk) 2004-04-06
PL319754A1 (en) 1997-08-18
NO971796D0 (no) 1997-04-18
EP0787115B1 (de) 2000-01-05
PT787115E (pt) 2000-05-31
WO1996012692A1 (de) 1996-05-02
CZ295528B6 (cs) 2005-08-17
CA2203183C (en) 2008-04-08
RU2146258C1 (ru) 2000-03-10
CA2203183A1 (en) 1996-05-02

Similar Documents

Publication Publication Date Title
BG62133B1 (bg) Метод за получаване на производни на4а,5,9,10,11,12-хексахидро-6н-бензофуро (3а,3,2-еf)(2)бензазепин
ES2219661T3 (es) Intermedios en al preparacion farmaceutica de camptotecina.
Crumbie et al. . alpha.-Nitro ketones and esters from acylimidazoles
US6407229B1 (en) Processes for the preparation of derivatives of 4a,5,9,10,11,12-hexahydro-6H-benzofuro-[3a,3,2-ef][2] benzazapine
EP0876373B1 (en) Method for preparing camptothecin derivatives
Trauner New ventures in the construction of complex heterocycles: synthesis of morphine and hasubanan alkaloids
AT401058B (de) Verfahren zum herstellen von derivaten des 4a,5, 9,10,11,12,-hexahydro-6h-benzofuro(3a,-3,2-ef) (2)benzazepins
US7423152B2 (en) Process for the manufacture of intermediates in camptothecin production
Keglevich et al. The chemistry of galanthamine. classical synthetic methods and comprehensive study on its analogues
Pandey et al. Synthesis of polyfunctional quinolizidine alkaloids: development towards selective glycosidase inhibitors
US7109327B2 (en) Total synthesis of galanthamine, analogues and derivatives thereof
US6716982B2 (en) Method for preparing camptothecin derivatives
JP2003183277A (ja) エピヒマンドラビン誘導体
Dong New synthetic reactions: Applications to discorhabdins and carbacephems
EP0251713A2 (en) Enantioselective synthesis of 1,3,4,6,7,12B (S)- hexahydro-2H-bezo (B) furo (2,3-A) quinolizin-2-one
US20030045719A1 (en) Preparation of a camptothecin derivative by intramolecular cyclisation
BG64485B1 (bg) Метод за получаване на (-) - галантамин хидробромид